Michel Afargan
Head of Pharmacology DevelopmentDr. Michel Afargan, Ph.D. is a Head of Pharmacology Development at Aprea Therapeutics, Inc (formerly known as Atrin Pharmaceuticals LLC) since 2018. He serves as Chief Executive Officer and Senior Expert at T MAY BIOPHARMA. He served as Chief Executive Officer of LifeWave Ltd., since November 2007. Dr. Afargan served as Director and Interim Chairman of LifeWave Ltd., since November 2007. Dr. Afargan served as Director of Strategic Development of Intec Pharma Ltd. Dr. Afargan is an expert in biopharmacy, with over 12 years of experience in the biopharmaceutical industry. He is founder of HPBM Ltd. and served as its Chief Executive Officer. Dr. Afargan founded the Israeli consortium Pharmalogica. He has five academic degrees; Bs.c. and Ms.c. in Life sciences from Ben-Gurion University, Beer-sheva, Israel, Pharmacist (B. Pharm.), Ms.c. Pharm and Ph.D. in Medicinal Chemistry and Pharmaceutical sciences from Hebrew University, Jerusalem, Israel.
Positions
- Company NameAprea Therapeutics, Inc.Stock CodeAPREPositionHead of Pharmacology DevelopmentColleagues
- OGOren GiladCo-Founder, CEO, President & Director
- RPRichard PetersIndependent Chairperson of the Board
- JPJohn P. HamillSenior VP, CFO, Principal Accounting Officer & Secretary
- LBLars B. AbrahmsenSenior VP & Chief Scientific Officer
- BWBrian WileySenior Vice President of Corporate Development & Strategy
- MJMichael J. GrissingerIndependent Director
- JBJohn B. HennemanIndependent Director
- RPRifat PamukcuIndependent Director
